Mediterranean Diet and Gestational Diabetes: What Holds Up

A Mediterranean-style diet started before conception or early in pregnancy probably lowers the risk of gestational diabetes mellitus (GDM). Three meta-analyses that draw on different kinds of evidence point in that direction. The catch: the randomized evidence comes from only three trials, and no study has shown that this pattern beats other high-quality diets such as DASH or a low-glycemic approach.

That distinction matters. "Mediterranean diet" can mean vegetables, legumes, fruit, whole grains, fish, olive oil, nuts, and less refined carbohydrate—but it can also mean a score on a food questionnaire. Those are related ideas, not interchangeable treatments. The evidence supports improving diet quality early; it does not settle whether olive oil, pistachios, or Mediterranean branding deserve the credit.

Three different evidence streams point the same way

The strongest causal evidence comes from a 2024 meta-analysis of randomized controlled trials by Waugh et al. It combined three trials with 2,348 participants. Compared with an unsupplemented Mediterranean diet, an intervention that included extra-virgin olive oil and pistachios produced a GDM risk ratio of 0.71 (95% CI, 0.57–0.88). Compared with a standard UK diet, a Mediterranean diet also produced a risk ratio of 0.71 (95% CI, 0.55–0.90). Both confidence intervals exclude 1.0, so the pooled results were statistically significant.

A risk ratio of 0.71 corresponds to a 29% relative reduction, not a 29-percentage-point reduction in the number of people who develop GDM. The absolute benefit depends on a person's baseline risk, which varies with factors such as prior GDM, pre-pregnancy weight, family history, age, and population.

Two other syntheses arrive at a similar direction through less experimentally clean routes. A 2024 observational meta-analysis by Jafari Nasab et al. included 10 studies and 32,959,909 participants. Individual cohort estimates ranged from a relative risk of 0.76 to 0.56, with one study reporting an odds ratio of 0.618. These findings fit a lower GDM risk among people with higher adherence, but they cannot prove that the diet caused the difference.

A 2025 review of clinical trials by Chagas et al., which included randomized and non-randomized studies, reported GDM in 15.2% of Mediterranean diet groups and 18.5% of control groups. That 3.3-percentage-point difference is useful context, but it is a raw comparison across a heterogeneous trial pool, not a pooled relative-risk estimate. It should not be treated as the precise absolute effect of a Mediterranean diet prescription.

Agreement across randomized trials, non-randomized clinical studies, and prospective cohorts increases confidence that early dietary improvement matters. It does not erase the biases unique to each design.

What the trials actually tested

The randomized signal is smaller and more specific than headlines usually admit. It rests on three primary trials, largely from Spain and the UK. In two of the three trials, researchers gave intervention participants free extra-virgin olive oil and pistachios. That design tests more than advice to eat Mediterranean-style food: it combines a dietary pattern with particular foods, free provisions, and likely more attention.

Diet trials also cannot blind participants or staff. People know whether they received food, counseling, or an intervention package. This creates unavoidable performance bias and makes it harder to isolate the effect of the foods themselves from changes in motivation, contact with clinicians, or other health behaviors.

The identical 0.71 point estimate across the two comparisons in the Waugh analysis looks neat, but it should not be mistaken for unusual precision. With only three underlying trials, a single large negative trial could substantially change the pooled result. The trial evidence supports a benefit; it does not provide a final answer for every population or every version of the diet.

Early timing has the best support

Timing may matter as much as the menu. In a 2025 randomized clinical trial by Martín-O'Connor et al., a nutritionist-guided Mediterranean diet intervention began before 12 weeks' gestation and reduced GDM rates. A video-guided version also reduced GDM incidence, suggesting that structured support can work outside a traditional face-to-face format. The supplied results do not establish whether starting in the second or third trimester works as well, because no trial has randomized participants to different start times.

The pre-conception period may also matter. A prospective Greek cohort study found that higher Mediterranean diet adherence before pregnancy was associated with lower GDM risk. Another Greek cohort, the BORN 2020 study, found that pre-conception physical activity was associated with lower GDM risk and examined its joint relationship with Mediterranean diet adherence. These are associations, not proof that either behavior alone prevents GDM, but they support addressing both before pregnancy when possible.

The diet may be a proxy for overall diet quality

The central unanswered question is specificity. Is the Mediterranean pattern uniquely useful, or does it work because it tends to displace refined carbohydrates and improve overall food quality?

A 2025 prospective cohort study by Tranidou et al. found that food-specific glycemic load was independently associated with GDM risk within Mediterranean dietary patterns. That result makes refined-carbohydrate displacement a plausible contributor. It does not prove a mechanism, and it does not identify olive-oil monounsaturated fat, polyphenols, fiber, inflammation, insulin resistance, or the gut microbiome as the causal pathway in pregnant people.

Several studies challenge Mediterranean-diet exceptionalism. A well-powered prospective longitudinal study by Li et al. found no lower GDM risk across higher Alternate Mediterranean Diet score quartiles when diet was assessed at weeks 16–22 or 24–29. Its Mediterranean, Healthy Eating Index, and DASH scores moved in similar directions rather than showing a Mediterranean-specific advantage.

Likewise, a cross-sectional Australian study found associations between both Mediterranean Diet Score and DASH score and GDM, without evidence that Mediterranean eating outperformed DASH. A prospective cohort using several diet-pattern methods found mixed results depending on how the pattern was derived, as reported by Wang et al.. These disagreements may reflect different populations, timing of dietary assessment, score definitions, confounder adjustment, and study design. They also make it inappropriate to declare one named diet the universal winner.

Other outcomes and the long view

The GDM finding does not sit alone. Chagas et al. reported preeclampsia in 6.9% of Mediterranean diet groups versus 9.5% of controls, along with lower preterm birth and small-for-gestational-age rates. A 2025 systematic review by Sharma et al. similarly found support across GDM, preeclampsia, and excessive gestational weight gain, while a 2024 meta-analysis by Xu et al. extended the literature to perinatal outcomes. These results add context, but different endpoints and study designs should not be compressed into one guaranteed maternal-fetal benefit.

For long-term maternal health, the most relevant evidence comes from one place: a three-year postpartum follow-up by Melero et al. of the San Carlos cohort. Participants assigned to an early Mediterranean-based intervention had lower rates of metabolic syndrome and abnormal glucose regulation three years after delivery. This is encouraging, but it is single-center follow-up evidence. It needs replication before anyone promises lower future type 2 diabetes risk.

A practical, evidence-matched recommendation

If you are planning pregnancy or are in early pregnancy, a Mediterranean-style pattern is a reasonable choice: emphasize vegetables, legumes, fruit, whole grains, nuts, fish, and unsaturated fats; reduce refined-carbohydrate load; and seek qualified prenatal nutrition guidance when available. Starting before conception or before 12 weeks has the most direct support.

• Expect risk reduction, not immunity from GDM.
• Choose a sustainable high-quality pattern rather than chasing a supposedly magic ingredient.
• Pair dietary changes with appropriate pre-conception physical activity.
• Discuss individualized nutrition and GDM screening with your obstetric clinician, especially after prior GDM or with other risk factors.

The evidence supports early, structured diet-quality improvement with moderate confidence. It does not show that Mediterranean eating is superior to every other high-quality pregnancy diet, or explain exactly why it may reduce GDM risk.